Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Cleveland Clinic Journal of Medicine
|
November 1, 1989
Familial polycythemia vera
R L Miller, J D Purvis, J K Weick
British Journal of Pharmacology
|
December 13, 2021
Bruton's TK regulates myeloid cell recruitment during acute inflammation
Gareth S D Purvis, Haidee Aranda-Tavio, Keith M Channon, et al.
Cells
|
June 19, 2024
Ly6C<sup>hi</sup> Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation
Gareth S D Purvis, Eileen McNeill, Benjamin Wright, et al.
Frontiers in Immunology
|
July 25, 2022
A Human CD68 Promoter-Driven Inducible Cre-Recombinase Mouse Line Allows Specific Targeting of Tissue Resident Macrophages
Agata N Rumianek, Ben Davies, Keith M Channon, et al.
Journal of the American Veterinary Medical Association
|
January 15, 1991
Segmental spinal fixation of a thoracic vertebral fracture in an adult chimpanzee
A Shores, J D Purvis, D Jones, et al.
American Journal of Clinical Oncology
|
October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study
R M Bukowski, A Theodors, J D Purvis, et al.
Ophthalmology
|
March 1, 1985
Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas
D F Miller, J W Bay, R J Lederman, et al.
Cancer Treatment Reports
|
July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer
J Mortimer, R B Livingston, I J Hardesty, et al.
Cancer Chemotherapy and Pharmacology
|
August 24, 1999
Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule
J P Stevenson, D DeMaria, D Reilly, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment
|
May 17, 2011
Development and validation of a potentiometric biosensor assay for tylosin with demonstrated applicability for the detection of two other antimicrobial growth-promoter compounds in feedstuffs
S L Stead, K B Wolodko-Cierniak, S F Richmond, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Cleveland Clinic Journal of Medicine
|
November 1, 1989
Familial polycythemia vera
R L Miller, J D Purvis, J K Weick
British Journal of Pharmacology
|
December 13, 2021
Bruton's TK regulates myeloid cell recruitment during acute inflammation
Gareth S D Purvis, Haidee Aranda-Tavio, Keith M Channon, et al.
Cells
|
June 19, 2024
Ly6C<sup>hi</sup> Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation
Gareth S D Purvis, Eileen McNeill, Benjamin Wright, et al.
Frontiers in Immunology
|
July 25, 2022
A Human CD68 Promoter-Driven Inducible Cre-Recombinase Mouse Line Allows Specific Targeting of Tissue Resident Macrophages
Agata N Rumianek, Ben Davies, Keith M Channon, et al.
Journal of the American Veterinary Medical Association
|
January 15, 1991
Segmental spinal fixation of a thoracic vertebral fracture in an adult chimpanzee
A Shores, J D Purvis, D Jones, et al.
American Journal of Clinical Oncology
|
October 1, 1987
Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study
R M Bukowski, A Theodors, J D Purvis, et al.
Ophthalmology
|
March 1, 1985
Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas
D F Miller, J W Bay, R J Lederman, et al.
Cancer Treatment Reports
|
July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer
J Mortimer, R B Livingston, I J Hardesty, et al.
Cancer Chemotherapy and Pharmacology
|
August 24, 1999
Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule
J P Stevenson, D DeMaria, D Reilly, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment
|
May 17, 2011
Development and validation of a potentiometric biosensor assay for tylosin with demonstrated applicability for the detection of two other antimicrobial growth-promoter compounds in feedstuffs
S L Stead, K B Wolodko-Cierniak, S F Richmond, et al.
Page
of 5